...
首页> 外文期刊>Infection and immunity >A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity
【24h】

A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity

机译:图拉弗朗西斯菌活疫苗株的一种确定的O-抗原多糖突变体在保持其保护能力的同时减弱了毒力

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Francisella tularensis, the causative agent of tularemia, has been designated a CDC category A select agent because of its low infective dose (<10 CFU), its ready transmission by aerosol, and its ability to produce severe morbidity and high mortality. The identification and characterization of this organism's virulence determinants will facilitate the development of a safe and effective vaccine. We report that inactivation of the wbtA-encoded dehydratase of the O-antigen polysaccharide (O-PS) locus of the still-unlicensed live vaccine strain of F. tularensis (LVS) results in a mutant (the LVS wbtA mutant) with remarkably attenuated virulence. Western blot analysis and immune electron microscopy studies associate this loss of virulence with a complete lack of surface O-PS expression. A likely mechanism for attenuation is shown to be the transformation from serum resistance in the wild-type strain to serum sensitivity in the mutant. Despite this significant attenuation in virulence, the LVS wbtA mutant remains immunogenic and confers protective immunity on mice against challenge with an otherwise lethal dose of either F. tularensis LVS or a fully virulent clinical isolate of F. tularensis type B. Recognition and characterization of the pivotal role of O-PS in the virulence of this intracellular bacterial pathogen may have broad implications for the creation of a safe and efficacious vaccine.
机译:Tularemia的致病菌 tularensis 因其低感染剂量(<10 CFU),易于通过气溶胶传播以及产生严重发病能力而被指定为CDC A类选择药物和高死亡率。鉴定和表征该生物的毒力决定因素将有助于开发安全有效的疫苗。我们报告说, F的仍未获得许可的活疫苗菌株的O-抗原多糖(O-PS)基因座的 wbtA 编码的脱水酶失活。 tularensis (LVS)导致突变体(LVS wbtA 突变体)的毒力明显减弱。 Western印迹分析和免疫电子显微镜研究将这种毒力丧失与表面O-PS表达的完全缺乏联系在一起。已表明减毒的可能机制是从野生型菌株的血清抗性到突变体的血清敏感性的转化。尽管毒力显着降低,LVS wbtA 突变体仍具有免疫原性,并赋予小鼠保护性免疫力,使其免受致命剂量的任一种 F攻击。 tularensis LVS或 F的全毒力临床分离株。 B. tularensis 。O-PS在这种细胞内细菌病原体毒力中的关键作用的识别和表征可能对创建安全有效的疫苗具有广泛的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号